## **Core Concept**
Disseminated Intravascular Coagulation (DIC) is a serious disorder in which the proteins responsible for blood clotting become overactive, leading to widespread clot formation and bleeding. In the context of Acute Myeloid Leukemia (AML), certain subtypes are more commonly associated with DIC due to the release of pro-coagulant substances by the leukemic cells.

## **Why the Correct Answer is Right**
The correct answer, Acute Promyelocytic Leukemia (APL) or AML-M3, is particularly associated with DIC. This subtype of AML is characterized by the accumulation of immature granulocytes (promyelocytes) in the bone marrow and peripheral blood. APL cells release granules that contain pro-coagulant factors, tissue factor, and other substances which initiate the coagulation cascade, leading to DIC. The high risk of DIC in APL is a well-established clinical feature and a major cause of morbidity and mortality in these patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other subtypes of AML can have coagulopathies, they are not as strongly associated with DIC as APL.
- **Option B:** This option does not specifically relate to a subtype of AML commonly linked with DIC.
- **Option D:** Similarly, this option does not correspond to a subtype of AML with a notable association with DIC.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that APL (AML-M3) is uniquely associated with DIC and also with a specific and effective treatment using all-trans retinoic acid (ATRA) and arsenic trioxide, which can help to differentiate it from other forms of AML and guide management.

## **Correct Answer:** . Acute Promyelocytic Leukemia (APL) or AML-M3